Parkinson Disease Parkinson disease is an idiopathic, slowly progressive, degenerative disorder characterized by resting tremor, stiffness (rigidity),

Slides:



Advertisements
Similar presentations
Extrapyramidal disorder and movement disorder
Advertisements

MOTOR NEURON DISEASE The motor neuron diseases (or motor neuron diseases) (MND) are a group of neurological disorders that selectively affect motor neurons.
Loghman hospital – farhad mansouri. IS THE GRAY MATTER INVOLVED? level of conciousness content of conciousness.
Evaluation of Movement Disorders
Cortically OriginatedMovement Cortically Originated Movement I. Motor Tract (corticospinal tractus) Extrapyramidal System (basal ganglia) Cerebellum Praxis.
Parkinson’s Disease (PD)
The PARticulars of Parkinson’s Disease
Parkinson’s Disease Dr Rachel Cary, Warwick Hospital.
Idiopathic parkinson’s disease (IPD)
Basal Ganglia: PATHOLOGIES Emma & Amrit. PARKINSON’S HUNTONGTON’S BALISMUS/HEMIBALISMUS ATHETOSIS WILSON’S DISEASE.
EXTRAPYRAMIDAL SYSTEM DISORDERS BASAL GANGLION DYSFUNCTION BASAL GANGLION DYSFUNCTION.
PHL 437/Pharmacogenomics Fourth Lecture (Parkinson’s disease) By Abdelkader Ashour, Ph.D. Phone:
Paul Short, Ph.D. The Parkinson’s Coach NEUROPSYCHOLOGY OF PARKINSON’S COMMUNICATION PROBLEMS.
Primary Symptoms It is important to note that not all patients experience the full range of symptoms; in fact, most do not. Rigidity is an increased tone.
BASAL GANGLIA PHARMACOLOGY Sammy Case & Matt Vreugde
Prepared by: Muhammad Ibrahim khan BS.PT(Pak), MS.PT(Pak), NCC(AKUH), CHPE(KMU)
Initial Diagnosis and Management of Parkinson’s Disease
Parkinson’s Disease By Nik Sanyal.
Module 7.3 Movement Disorders. Parkinson’s Disease A neurological disorder characterized by muscle tremors, rigidity, slow movements and difficulty initiating.
Basal ganglia & cerebellar pathology
Erica Partridge Parkinson’s Disease. Definition Aetiology PD vs Parkinsonism Symptoms and signs Differentials Investigations Management Prognosis.
Parkinson’s Disease Busra Berika Yucel
Parkinson ’ s disease. Function Anatomy of Parkinson ’ s Disease.
Neuromuscular Disorders Brenda P. Johnson, PhD, RN.
JP Parkinson’s Disease. Overview Idiopathic PD Clinically and pathologically distinct from other parkinsonian syndromes Degenerative disorder of the CNS.
Parkinson’s Disease By Devin Cornford
Neurological Manifestations of Wilson’s Disease Aleksandar Videnovic, MD, MSc Assistant Professor of Neurology Feinberg School of Medicine Northwestern.
Parkinson’s Disease. Definition Parkinson's disease (PD) is an idiopathic, slowly progressive, neurodegenerative disorder whereby two or more of the following.
Parkinson’s Disease superKAT :).
PhD MD MBBS Faculty of Medicine Al Maarefa Colleges of Science & Technology Faculty of Medicine Al Maarefa Colleges of Science & Technology Lecture – 9:
Adult Medical-Surgical Nursing Neurology Module: Parkinson’s Disease.
Movement Disorders K. Zárubová. Movement disorders MD - abnornal involuntary movements dysfunction of basal ganglia (anatomically) dysfunction of extrapyramidal.
Mostly Parkinson’s disease but also few other movement disorders due to diseases of the basal ganglia.
 Parkinson’s Disease (PD) -progressive neurodegenerative disease affecting motor ability -third most common neurologic disorder of older adults.
A neurology primer. Idiopathic Parkinson Disease (also referred to as primary or classical Parkinson disease)  is a progressive neurodegenerative disorder.
Movement disorders Dr.Zana A. Mohammed M.B.Ch.B, F.I.B.M.S. NEUROLOGY
second most common neurodegenerative disorder progressive loss of muscle control trembling of the limbs and head while at rest stiffness, slowness, and.
Parkinson's disease By Colby Allen. symptoms Mild to major tremors. Rigidity or joint stiffness Bradykinesia or slowness of movement Postural instability.
PARKINSON’S DISEASE.
The Substantia Nigra THE BRAIN Symptoms differ from every person suffering from the disease. There are two types of symptoms, primary, secondary.
Extrapyramidal pathway
PARKINSON’S DISEASE Jeanette J. Norden, Ph.D. Professor Emerita Vanderbilt University School of Medicine.
Pathogenesis and pathology of parkinsonism
Primary Symptoms It is important to note that not all patients experience the full range of symptoms; in fact, most do not. Rigidity is an increased tone.
Parkinson's disease ♦ Is a neurodegenerative disorder ♦ Develops around age 50 * incidence rises with age * affects 1-2% of population > age 65 ♦ Higher.
Team (Phoenix) Presents Parkinson’s Disease Prepared in partial satisfaction of the requirements for GPC 126, Physiological Psychology Spring Semester,
Direct motor pathway Corticospinal pathway. Motor Units – Large Versus Small Text Fig
 DEFINITION: It includes all fibers that can influence the motor end plate activity and do not pass in the pyramidal tract.
Parkinson’s disease by Syed Baseeruddin Alvi (09).
DISORDERS OF THE MOTOR SYSTEM
Drugs Used for Parkinson’s Disease
MOVEMENT DISORDERS ANATOMY The basal ganglia refer to
Parkinson’s Disease.
Nervous System Disorders and Homeostatic Imbalances
Module 7.3 Movement Disorders
MOVEMENT DISORDERS.
Parkinson's disease KRZYSZTOF NICPOŃ.
EXTRAPYRAMIDAL SYSTEM DISORDERS
“The effects of chronic changes to the functioning of the nervous system due to interference to neurotransmitter function, illustrated by the role of Dopamine.
Parkinson's disease Parkinson's disease (PD) is the second-most common
The Approach to Tremor (with case examples) Praveen Dayalu MD Associate Professor Department of Neurology University of Michigan.
Introduction to movement disorders and parkinsonism
Domina Petric, MD Huntington´s disease.
Drug-induced dyskinesias
Drugs for Degenerative Diseases of the Nervous System
Basal ganglia It is a collection of grey matter deeply in each
Neurodegenerative diseases
FUNCTIONS OF THE BASAL NUCLEI FUNCTIONS OF THE BASAL NUCLEI assist in the regulation of voluntary movement & the learning of motor skills initiate movement.
Parkinson’s Disease Definitions Disease features Pathology
HOW DOES EXPERIENCE AFFECT BEHAVIOUR AND MENTAL PROCESSES?
Presentation transcript:

MOVEMENTS DISORDERS DISEASES OF EXTRAPYRAMIDAL SYSTEM DISEASES OF BASAL GANGLIA

Parkinson Disease Parkinson disease is an idiopathic, slowly progressive, degenerative disorder characterized by resting tremor, stiffness (rigidity), slow and decreased movement (bradykinesia), and gait and/or postural instability. Parkinson disease (PD) affects about 0.4% of people > 40 yr, 1% of people ≥ 65 yr, and 10% of people≥ 80 yr. The mean age at onset is about 57 yr

Rarely, PD begins during childhood or adolescence (juvenile parkinsonism). Onset between ages 21 and 40 yr is sometimes called early-onset PD

Pathophysiology Synuclein is a neuronal and glial cell protein that can aggregate into insoluble fibrils and form Lewy bodies. The pathologic hallmark of PD is synuclein-filled Lewy bodies in the nigrostriatal system. In PD, pigmented neurons of the substantia nigra, locus ceruleus, and other brain stem dopaminergic cell groups degenerate. Loss of substantia nigra neurons results in depletion of dopamine in the dorsal aspect of the putamen (part of the basal ganglia) and causes many of the motor manifestations of PD

Etiology A genetic predisposition is likely, at least in some cases. About 10% of patients have a family history of PD. Several abnormal genes have been identified. Inheritance is autosomal dominant for some genes and autosomal recessive for others. In genetic forms, age at onset tends to be younger, but the course is typically more benign than that of later-onset,

Symptoms and Signs In most patients, the disease begins insidiously. A resting tremor of one hand is often the first symptom. The tremor is characterized as follows Slow and coarse Maximal at rest, lessening during movement, and absent during sleep Amplitude increased by emotional tension or fatigue

Often involving the wrist and fingers, sometimes involving the thumb moving against the index finger (pill rolling), as when people roll a pill in their hand or handle a small object Usually, the hands or feet are affected first, most often asymmetrically. The jaw and tongue may also be affected, but not the voice. Tremor may become less prominent as the disease progresses

Rigidity develops independently of tremor in many patients Rigidity develops independently of tremor in many patients. When a clinician moves a rigid joint, semirhythmic jerks due to variations in the intensity of the rigidity occur, producing a ratchet-like effect (cogwheel rigidity). Slow movements (bradykinesia) are typical. Movement also becomes decreased in amplitude (hypokinesia) and difficult to initiate (akinesia

Rigidity and hypokinesia may contribute to muscle aches and sensations of fatigue. The face becomes masklike (hypomimic), with an open mouth and reduced blinking. Excessive drooling (sialorrhea) may contribute to disability. Speech becomes hypophonic, with characteristic monotonous, sometimes stuttering dysarthria. Hypokinesia and impaired control of distal muscles cause micrographia (writing in very small letters) and make activities of daily living increasingly difficult. Without warning, voluntary movement, including walking, may suddenly halt (called freezing of gait

Postural instability may develop, resulting in falls, which occur later in PD. Patients have difficulty starting to walk, turning, and stopping. They shuffle, taking short steps, holding their arms flexed to the waist, and swinging their arms little or not at all with each stride. Steps may inadvertently quicken, while stride length progressively shortens; this gait abnormality, called festination, is often a precursor to freezing of gait. A tendency to fall forward (propulsion) or backward (retropulsion) when the center of gravity is displaced

Dementia Sleep disorders are common.

Neurologic symptoms unrelated to parkinsonism commonly develop because synucleinopathy occurs in other areas of the central, peripheral, and autonomic nervous systems. Almost universal sympathetic denervation of the heart, contributing to orthostatic hypotension Esophageal dysmotility, contributing to dysphagia and increased risk of aspiration Lower bowel dysmotility, contributing to constipation Urinary hesitancy and/or urgency, potentially leading to incontinence (common) Anosmia (common) In some patients, some of these symptoms occur before the motor symptoms of PD. Seborrheic dermatitis is also common

Diagnosis Mainly clinical evaluation, based on motor symptom

Treatment Carbidopa/levodopa (mainstay of treatment) Amantadine MAO type B (MAO-B) inhibitors, or, in few patients, anticholinergic drugs Dopamine agonists Catechol O-methyltransferase (COMT) inhibitors, always used with levodopa, particularly when response to levodopa is wearing off Surgery if drugs do not sufficiently control symptoms or have intolerable side effects

Chorea Movements are nonrhythmic, jerky, rapid, and nonsuppressible, primarily in distal muscles or the face. Sometimes abnormal movements are incorporated into semipurposeful acts that mask the involuntary movements. Chorea often occurs with athetosis as choreoathetosis

Huntington disease, hyperthyroidism, hypoparathyroidism, paraneoplastic syndromes, SLE affecting the CNS, other autoimmune disorders, rheumatic fever, tumors or infarcts of the caudate nucleus or putamen Pregnancy, often in women who had rheumatic fever Senile chorea Drugs that can cause chorea (eg, levodopa, phenytoin , cocaine, oral contraceptives Drugs that can cause tardive dyskinesia (eg, antipsychotics

Athetosis (slow chorea) is nonrhythmic, slow, writhing, sinuous movements predominantly in distal muscles, often alternating with postures of the proximal limbs. Huntington disease, encephalitis, hepatic encephalopathy Drugs (eg, cocaine, amphetamines, antipsychotics

Hemiballismusis unilateral rapid, nonrhythmic, nonsuppressible, wildly flinging movement of the proximal arm and/or leg; rarely, such movement occurs bilaterally (ballismus). Hemiballismus is a severe form of chorea

Dystonias Sustained muscle contractions often distort body posture or cause twisting, repetitive movements. Primary (idiopathic) Degenerative or metabolic disorders (eg, Wilson disease, various lipidoses, multiple sclerosis, cerebral palsy, stroke, brain hypoxia) Drugs that block dopamine receptors, most often antipsychotics (eg, phenothiazines, thioxanthenes, butyrophenones) or antiemetics